PepsiCo Prices Two-Tranche Euro Bond as Analysts Trim Targets Without Downgrading the Stock

PepsiCo sold EUR 1 billion in bonds due 2029 and 2035, while Goldman Sachs and Piper Sandler trimmed price targets but kept their ratings.

PepsiCo has moved ahead with a EUR 1 billion euro-denominated bond sale, splitting the issue into two equal tranches of EUR 500 million each. The shorter piece carries a 3.750% coupon and matures in 2029, while the longer tranche offers 4.250% and comes due in 2035 — a structure that spreads the company's repayment dates across separate years and pairs the extended horizon with a richer yield.

Settlement is expected on October 16, 2026. Proceeds are earmarked for general corporate purposes, with PepsiCo explicitly naming the repayment of commercial paper — its short-term debt instruments — among the possible uses. That detail matters: the financing could serve to swap near-term obligations for longer-dated borrowings, but it does not amount to a committed investment program. The deal's terms have been filed and the placement reported as completed; either way, the transaction addresses the funding side of the business, not its earnings trajectory.

Price Targets Cut, Ratings Left Alone

The bond news landed alongside a fresh round of cautious analyst revisions. Goldman Sachs lowered its price target to $165 from $180 on Thursday, keeping its buy rating intact. Piper Sandler followed on Friday, with Michael Lavery cutting his target to $140 from $176 while maintaining an overweight recommendation. Other analysts have likewise trimmed their targets without abandoning their existing calls.

That pattern is the real story on the sell side: a target reduction is not the same thing as a downgrade. The direction of travel is clear — targets are coming down — but recommendations still straddle the line between bullish and neutral. Even analysts who remain constructive have adjusted their valuation yardsticks.

Revenue and Profit Are Telling Different Stories

PepsiCo narrowed its organic revenue guidance to roughly 3%, yet simultaneously raised its outlook for reported revenue growth. Those two trajectories do not point the same way, and that divergence sits at the heart of how the stock should be assessed.

In the third fiscal quarter of 2026, net revenue reached $25.274 billion, up 5.6%, while adjusted earnings per share rose 2%. Top-line momentum and bottom-line pressure are running on separate tracks.

Operationally, North American demand and higher input costs remain the pressure points. According to media reports, the company is planning further cost reductions along with investments in innovation and marketing across North America. For shareholders, financing and business performance stay distinct tests: the bond terms firm up the planned fundraising, but they do nothing to resolve the strains in the operating business — and they offer no counterargument to the more guarded profit expectations that prompted the target cuts in the first place.